首页> 美国卫生研究院文献>Case Reports in Oncology >Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review
【2h】

Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review

机译:紫杉烷类化学疗法在晚期皮脂腺癌中的成功治疗:病例报告和文献复习。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

For sebaceous carcinoma (SC), a rare malignant tumor, no standard chemotherapy regimen for patients with distant metastasis has been studied. We experienced a case of eyelid SC with multiple lung metastases that responded to combination chemotherapy with carboplatin and paclitaxel with 11-month progression-free survival (PFS). This patient also responded to second-line treatment with docetaxel, another taxane, with 7-month PFS, resulting in at least 18 months of survival at the time of reporting. This report shows that taxane-based chemotherapy may be effective for advanced SC, for which no standard therapy has been established.
机译:对于皮脂腺癌(SC)这种罕见的恶性肿瘤,尚无针对远处转移患者的标准化疗方案的研究。我们经历了一个眼睑SC多肺转移的病例,该病例对卡铂和紫杉醇联合化疗有11个月无进展生存期(PFS)的反应。该患者对另一种紫杉烷多西紫杉醇的二线治疗也有反应,PFS为7个月,报告时至少存活18个月。该报告表明,基于紫杉烷类的化疗可能对晚期SC有效,而尚无标准疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号